Source:http://linkedlifedata.com/resource/pubmed/id/19821142
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-1-21
|
pubmed:abstractText |
L-2-hydroxyglutaric aciduria (L-2-HGA) is a rare inherited autosomal recessive neurometabolic disorder caused by mutations in the gene encoding L-2-hydroxyglutarate dehydrogenase. An assay to evaluate L-2-hydroxyglutarate dehydrogenase (L-2-HGDH) activity in fibroblast, lymphoblast and/or lymphocyte lysates has hitherto been unavailable. We developed an L-2-HGDH enzyme assay in cell lysates based on the conversion of stable-isotope-labelled L-2-hydroxyglutarate to 2-ketoglutarate, which is converted into L-glutamate in situ. The formation of stable isotope labelled L-glutamate is therefore a direct measure of L-2-HGDH activity, and this product is detected by liquid chromatography-tandem mass spectrometry. A deficiency of L-2-HGDH activity was detected in cell lysates from 15 out of 15 L-2-HGA patients. Therefore, this specific assay confirmed the diagnosis unambiguously affirming the relationship between molecular and biochemical observations. Residual activity was detected in cells derived from one L-2-HGA patient. The L-2-HGDH assay will be valuable for examining in vitro riboflavin/FAD therapy to rescue L-2-HGDH activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1573-2665
|
pubmed:author |
pubmed-author:Aktuglu-ZeybekCC,
pubmed-author:BekriSS,
pubmed-author:ChristensenEE,
pubmed-author:ClarkeJJ,
pubmed-author:GibsonK MKM,
pubmed-author:HahnAA,
pubmed-author:JakobsCC,
pubmed-author:KormanS HSH,
pubmed-author:KranendijkMM,
pubmed-author:Mejaski-BosnjakVV,
pubmed-author:SalomonsG SGS,
pubmed-author:StruysE AEA,
pubmed-author:Superti-FurgaAA,
pubmed-author:Vianey-SabanCC,
pubmed-author:van der KnaapM SMS
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
713-9
|
pubmed:meshHeading |
pubmed-meshheading:19821142-Alcohol Oxidoreductases,
pubmed-meshheading:19821142-Animals,
pubmed-meshheading:19821142-Brain Diseases, Metabolic, Inborn,
pubmed-meshheading:19821142-Calibration,
pubmed-meshheading:19821142-Cell Extracts,
pubmed-meshheading:19821142-Cells, Cultured,
pubmed-meshheading:19821142-Chromatography, High Pressure Liquid,
pubmed-meshheading:19821142-Chromatography, Liquid,
pubmed-meshheading:19821142-Enzyme Assays,
pubmed-meshheading:19821142-Fibroblasts,
pubmed-meshheading:19821142-Humans,
pubmed-meshheading:19821142-Lymphocytes,
pubmed-meshheading:19821142-Models, Biological,
pubmed-meshheading:19821142-Models, Molecular,
pubmed-meshheading:19821142-Rats,
pubmed-meshheading:19821142-Research Design,
pubmed-meshheading:19821142-Tandem Mass Spectrometry
|
pubmed:year |
2009
|
pubmed:articleTitle |
Development and implementation of a novel assay for L-2-hydroxyglutarate dehydrogenase (L-2-HGDH) in cell lysates: L-2-HGDH deficiency in 15 patients with L-2-hydroxyglutaric aciduria.
|
pubmed:affiliation |
Metabolic Unit, Department of Clinical Chemistry, PK 1X 014, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|